740 related articles for article (PubMed ID: 25887471)
1. Dexamethasone in osteogenic medium strongly induces adipocyte differentiation of mouse bone marrow stromal cells and increases osteoblast differentiation.
Ghali O; Broux O; Falgayrac G; Haren N; van Leeuwen JP; Penel G; Hardouin P; Chauveau C
BMC Cell Biol; 2015 Mar; 16():9. PubMed ID: 25887471
[TBL] [Abstract][Full Text] [Related]
2. Adipogenic RNAs are transferred in osteoblasts via bone marrow adipocytes-derived extracellular vesicles (EVs).
Martin PJ; Haren N; Ghali O; Clabaut A; Chauveau C; Hardouin P; Broux O
BMC Cell Biol; 2015 Mar; 16():10. PubMed ID: 25887582
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
[TBL] [Abstract][Full Text] [Related]
4. Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.
Abdallah BM
J Biomed Sci; 2017 Feb; 24(1):11. PubMed ID: 28173811
[TBL] [Abstract][Full Text] [Related]
5. Participation of TNF-α in Inhibitory Effects of Adipocytes on Osteoblast Differentiation.
Abuna RP; De Oliveira FS; Santos Tde S; Guerra TR; Rosa AL; Beloti MM
J Cell Physiol; 2016 Jan; 231(1):204-14. PubMed ID: 26059069
[TBL] [Abstract][Full Text] [Related]
6. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
7. 3,5-dicaffeoyl‑epi-quinic acid from Atriplex gmelinii enhances the osteoblast differentiation of bone marrow-derived human mesenchymal stromal cells via WnT/BMP signaling and suppresses adipocyte differentiation via AMPK activation.
Karadeniz F; Oh JH; Lee JI; Seo Y; Kong CS
Phytomedicine; 2020 Jun; 71():153225. PubMed ID: 32464299
[TBL] [Abstract][Full Text] [Related]
8. CD200 expression in human cultured bone marrow mesenchymal stem cells is induced by pro-osteogenic and pro-inflammatory cues.
Pontikoglou C; Langonné A; Ba MA; Varin A; Rosset P; Charbord P; Sensébé L; Deschaseaux F
J Cell Mol Med; 2016 Apr; 20(4):655-65. PubMed ID: 26773707
[TBL] [Abstract][Full Text] [Related]
9. Adipose-derived mesenchymal stromal (stem) cells differentiate to osteoblast and chondroblast lineages upon incubation with conditioned media from dental pulp stem cell-derived osteoblasts and auricle cartilage chondrocytes.
Carbone A; Valente M; Annacontini L; Castellani S; Di Gioia S; Parisi D; Rucci M; Belgiovine G; Colombo C; Di Benedetto A; Mori G; Lo Muzio L; Maiorella A; Portincasa A; Conese M
J Biol Regul Homeost Agents; 2016; 30(1):111-22. PubMed ID: 27049081
[TBL] [Abstract][Full Text] [Related]
10. Osteogenic growth peptide C-terminal pentapeptide [OGP(10-14)] acts on rat bone marrow mesenchymal stem cells to promote differentiation to osteoblasts and to inhibit differentiation to adipocytes.
Chen ZX; Chang M; Peng YL; Zhao L; Zhan YR; Wang LJ; Wang R
Regul Pept; 2007 Jul; 142(1-2):16-23. PubMed ID: 17331598
[TBL] [Abstract][Full Text] [Related]
11. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
[TBL] [Abstract][Full Text] [Related]
12. Risedronate positively affects osteogenic differentiation of human mesenchymal stromal cells.
Casado-Díaz A; Santiago-Mora R; Dorado G; Quesada-Gómez JM
Arch Med Res; 2013 Jul; 44(5):325-34. PubMed ID: 23867791
[TBL] [Abstract][Full Text] [Related]
13. The osteogenic or adipogenic lineage commitment of human mesenchymal stem cells is determined by protein kinase C delta.
Lee S; Cho HY; Bui HT; Kang D
BMC Cell Biol; 2014 Nov; 15():42. PubMed ID: 25420887
[TBL] [Abstract][Full Text] [Related]
14. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
Zhong S; He X; Li Y; Lou X
Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.
Haÿ E; Dieudonné FX; Saidak Z; Marty C; Brun J; Da Nascimento S; Sonnet P; Marie PJ
J Cell Physiol; 2014 Nov; 229(11):1765-75. PubMed ID: 24664975
[TBL] [Abstract][Full Text] [Related]
16. Short-term exposure to tumor necrosis factor-alpha enables human osteoblasts to direct adipose tissue-derived mesenchymal stem cells into osteogenic differentiation.
Lu Z; Wang G; Dunstan CR; Zreiqat H
Stem Cells Dev; 2012 Sep; 21(13):2420-9. PubMed ID: 22296271
[TBL] [Abstract][Full Text] [Related]
17. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat.
Kha HT; Basseri B; Shouhed D; Richardson J; Tetradis S; Hahn TJ; Parhami F
J Bone Miner Res; 2004 May; 19(5):830-40. PubMed ID: 15068507
[TBL] [Abstract][Full Text] [Related]
18. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes.
Biver G; Wang N; Gartland A; Orriss I; Arnett TR; Boeynaems JM; Robaye B
Stem Cells; 2013 Dec; 31(12):2747-58. PubMed ID: 23629754
[TBL] [Abstract][Full Text] [Related]
19. Conditioned media cause increases in select osteogenic and adipogenic differentiation markers in mesenchymal stem cell cultures.
Maxson S; Burg KJ
J Tissue Eng Regen Med; 2008; 2(2-3):147-54. PubMed ID: 18383557
[TBL] [Abstract][Full Text] [Related]
20. Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells.
Yoon HY; Yun SI; Kim BY; Jin Q; Woo ER; Jeong SY; Chung YS
Eur J Pharmacol; 2011 Aug; 664(1-3):54-9. PubMed ID: 21550337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
